Mats Eliasson

8.5k total citations
143 papers, 5.0k citations indexed

About

Mats Eliasson is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mats Eliasson has authored 143 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Public Health, Environmental and Occupational Health and 32 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mats Eliasson's work include Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Nutritional Studies and Diet (22 papers) and Acute Myocardial Infarction Research (16 papers). Mats Eliasson is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Nutritional Studies and Diet (22 papers) and Acute Myocardial Infarction Research (16 papers). Mats Eliasson collaborates with scholars based in Sweden, Finland and Denmark. Mats Eliasson's co-authors include Stefan Söderberg, Dan Lundblad, Bernt Lindahl, Birgitta Stegmayr, Jan‐Håkan Jansson, Kjell Asplund, Tommy Olsson, Margareta Eriksson, Bernd Stegmayr and Per‐Eric Evrin and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Mats Eliasson

139 papers receiving 4.7k citations

Peers

Countries citing papers authored by Mats Eliasson

Since Specialization

Citations

This map shows the geographic impact of Mats Eliasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Eliasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Eliasson more than expected).

Fields of papers citing papers by Mats Eliasson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Eliasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Eliasson. The network helps show where Mats Eliasson may publish in the future.

Co-authorship network of co-authors of Mats Eliasson

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Eliasson. A scholar is included among the top collaborators of Mats Eliasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Eliasson. Mats Eliasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms 2020 ·Frontiers in Endocrinology ·Magdalena Keindl, (unknown), (unknown), Ruchi Jain, Brith Bergum, Troels Mygind Jensen, (unknown), Henrik Falhammar, Thomas Nyström, Sergiu‐Bogdan Catrina, Gun Jörneskog, Leif Groop, Mats Eliasson, Björn Eliasson, Kerstin Brismar, Peter M. Nilsson, Tore Julsrud Berg, Silke Appel, Valeriya Lyssenko	10
2	Time trends of vitamin D concentrations in northern Sweden between 1986 and 2014: a population-based cross-sectional study 2019 ·European Journal of Nutrition ·(unknown), Mats Eliasson, Robert Lundqvist, Stefan Söderberg, Tanja Zeller, Viktor Oskarsson	5
3	Differences in cardiovascular risk factors and socioeconomic status do not explain the increased risk of death after a first stroke in diabetic patients: results from the Swedish Stroke Register 2013 ·Diabetologia ·Marie Eriksson, Kjell Asplund, (unknown), Mats Eliasson	2
4	Abdominal and gynoid adipose distribution and incident myocardial infarction in women and men 2010 ·International Journal of Obesity ·Peter Wiklund, Fredrik Toss, J-H Jansson, Mats Eliasson, Göran Hallmans, Anna Nordström, Paul W. Franks, Peter Nordström	25
5	Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study 2010 ·American Journal of Clinical Nutrition ·Eva Warensjö, Jan‐Håkan Jansson, Tommy Cederholm, Kurt Boman, Mats Eliasson, Göran Hallmans, Ingegerd Johansson, Per Sjögren	102
6	The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender 2009 ·Cardiovascular Diabetology ·(unknown), Jaakko Tuomilehto, Tiina Laatikainen, Stefan Söderberg, Mats Eliasson, Peter M. Nilsson, Qing Qiao	25
7	Effect of Sibutramine on Weight Reduction in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial 2008 ·Obstetrical & Gynecological Survey ·(unknown), Marie Bixo, Inger Björn, Pål Wölner‐Hanssen, Mats Eliasson, Anders Larsson, Owe Johnson, Inger Sundström Poromaa	3
8	Gender differences in trends of acute myocardial infarction events: The Northern Sweden MONICA study 1985 – 2004 2008 ·BMC Cardiovascular Disorders ·Dan Lundblad, Lars Holmgren, Jan‐Håkan Jansson, Ulf Näslund, Mats Eliasson	50
9	Telomere Length Is Associated With Obesity Parameters but With a Gender Difference 2008 ·Obesity ·Katarina Nordfjäll, Mats Eliasson, Birgitta Stegmayr, Olle Melander, Peter M. Nilsson, Göran Roos	151
10	Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis 2008 ·Blood Coagulation & Fibrinolysis ·(unknown), Eva Rask, Owe Johnson, Kjell Carlström, Bo Åhrén, Mats Eliasson, Kurt Boman, Stefan Söderberg	7
11	Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial 2007 ·Fertility and Sterility ·(unknown), Marie Bixo, Inger Björn, Pål Wölner‐Hanssen, Mats Eliasson, Anders Larsson, Owe Johnson, Inger Sundström Poromaa	31
12	Hälsoekonomi får allt större roll för sjukvårdens prioriteringar 2006 ·Läkartidningen ·Per Carlsson, Anders Anell, Mats Eliasson	10
13	High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study 2003 ·Cardiovascular Diabetology ·Mats Eliasson, Jan‐Håkan Jansson, Bernt Lindahl, Birgitta Stegmayr	50
14	Quantitative Measurement of Carotid Atherosclerosis in Relation to Levels of Von Willebrand Factor and Fibrinolytic Variables in Plasma -- A 2-year Follow-Up Study 2002 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Torbjörn K. Nilsson, J. David Spence, Peter M. Nilsson, Mats Eliasson, Jan‐Håkan Jansson, Kurt Boman	4
15	[Duplicate publication a way of embellishing research results. Unethical misuse which threatens the validity of systematic reviews and meta-analysis]. 2000 ·PubMed ·Mats Eliasson	1
16	Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men 1999 ·Journal of the American College of Cardiology ·F. Huhtasaari, V. Lundberg, Mats Eliasson, Urban Janlert, Kjell Asplund	120
17	[More active therapy in diabetes type 2 is justified by findings in a break-through study. 20-year follow-up of over 5000 patients]. 1998 ·PubMed ·P.M. Nilsson, Stig Attvall, Mats Eliasson	1
18	Diabetes as a risk factor for myocardial infarction: population and gender perspectives 1997 ·Journal of Internal Medicine ·V. Lundberg, Bernd Stegmayr, Kjell Asplund, Mats Eliasson, F. Huhtasaari	112
19	Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: The Northern Sweden MONICA study 1994 ·Metabolism ·Mats Eliasson, Kjell Asplund, Per‐Eric Evrin, Bernt Lindahl, Dan Lundblad	43
20	Influence of smoking and snuff use on electrolytes, adrenal and calcium regulating hormones 1993 ·European Journal of Endocrinology ·Mats Eliasson, Erik Hägg, Dan Lundblad, Roger Karlsson, Elisabet Bucht	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact